Egetis Therapeutics AB (publ) (STO:EGTX)
3.590
-0.060 (-1.64%)
May 14, 2025, 9:00 AM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Emcitate | 57.60M |
Log In |
Log In |
Log In |
Log In |
Emcitate Growth | 163.01% |
Log In |
Log In |
Log In |
Log In |
PledOx | - |
Log In |
Log In |
Log In |
Log In |
PledOx Growth | - |
Log In |
Log In |
Log In |
Log In |
Common | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Germany | 16.90M |
Log In |
Log In |
Log In |
Log In |
Japan | 14.50M |
Log In |
Log In |
Log In |
Log In |
Japan Growth | 2316.67% |
Log In |
Log In |
Log In |
Log In |
France | 5.80M |
Log In |
Log In |
Log In |
Log In |
France Growth | 48.72% |
Log In |
Log In |
Log In |
Log In |
Spain | 5.00M |
Log In |
Log In |
Log In |
Log In |
Spain Growth | 47.06% |
Log In |
Log In |
Log In |
Log In |
Other Countries | 4.70M |
Log In |
Log In |
Log In |
Log In |
Other Countries Growth | 4.44% |
Log In |
Log In |
Log In |
Log In |
Poland | 2.60M |
Log In |
Log In |
Log In |
Log In |
Poland Growth | 52.94% |
Log In |
Log In |
Log In |
Log In |
Australia | 2.50M |
Log In |
Log In |
Log In |
Log In |
Australia Growth | 31.58% |
Log In |
Log In |
Log In |
Log In |
United Kingdom | 2.40M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Growth | -4.00% |
Log In |
Log In |
Log In |
Log In |
Italy | 2.00M |
Log In |
Log In |
Log In |
Log In |
Italy Growth | -9.09% |
Log In |
Log In |
Log In |
Log In |
Other | 1.30M |
Log In |
Log In |
Log In |
Log In |
Sweden | - |
Log In |
Log In |
Log In |
Log In |
Sweden Growth | - |
Log In |
Log In |
Log In |
Log In |
Europe | - |
Log In |
Log In |
Log In |
Log In |